# Argatroban in Critically Ill Patients With Heparin Resistance

> **NCT01734252** · PHASE2 · COMPLETED · sponsor: **Medical University Innsbruck** · enrollment: 44 (actual)

## Conditions studied

- Achievement of a Sufficient Thrombosis Prohpylaxis in Clitically Ill Patients With Heparin Resistance

## Interventions

- **DRUG:** Argatroban

## Key facts

- **NCT ID:** NCT01734252
- **Lead sponsor:** Medical University Innsbruck
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07-29
- **Primary completion:** 2016-04-01
- **Final completion:** 2016-04-01
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2017-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01734252

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01734252, "Argatroban in Critically Ill Patients With Heparin Resistance". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01734252. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*